Reported 11 months ago
LITE-ON is seizing AI business opportunities by offering integrated AI solutions including high-performance computing/AI servers and workstations, expecting a recovery in performance in the second half of the year. With achievements in smart healthcare, Chairman Lu Kunshan foresees a significant increase in this sector and aims for turnaround and profitability, planning for the independent development and IPO of its medical biotechnology business in two years. Despite challenges in the Chinese AI server market due to the US ban on high-end AI chips, projects like the NVIDIA special H20 series and closing AI server projects in the second half of the year are anticipated to boost LITE-ON's operational momentum. Additionally, LITE-ON's medical biotechnology business is showing promising results with innovative products like BtNPN plant nano patches, contributing to the company's goal of expanding its healthcare management opportunities domestically and internationally.
Source: YAHOO